序号 |
标题 |
次数 |
作者 |
发布时间 |
70786 |
DOTA-tris(t-Bu)-Amido-PEG4-Amine,大环化合物 |
64 |
kx |
2024-12-25 |
70787 |
mPEG36-Hydrazide 甲氧基三十六聚乙二醇-酰肼 |
83 |
h |
2024-12-25 |
70788 |
mPEG5-Hydrazide cas:1449390-64-0 甲氧基五聚乙二醇-酰肼 |
66 |
h |
2024-12-25 |
70789 |
DOTA-tris(t-Bu)-Amido-PEG5-Amine,大环配体 |
76 |
kx |
2024-12-25 |
70790 |
mPEG12-N3 cas:89485-61-0 甲氧基十二聚乙二醇-叠氮 |
74 |
h |
2024-12-25 |
70791 |
3-Azidopropylthioureidobenzyl DOTA,大环化合物 |
81 |
kx |
2024-12-25 |
70792 |
mPEG6-巯基 cas:441771-60-4 甲氧基六聚乙二醇-巯基 |
79 |
h |
2024-12-25 |
70793 |
DOTA-tris(t-Bu)-Amido-PEG12-NHS Ester,大环化合物 |
90 |
kx |
2024-12-25 |
70794 |
mPEG12-巯基 cas:134874-49-0 甲氧基十二聚乙二醇-巯基 |
70 |
h |
2024-12-25 |
70795 |
Cyclooctyne-O-PFP ester,886209-60-5,ADC试剂 |
71 |
hyy |
2024-12-25 |
70796 |
mPEG11-OCH2CH2COOH cas:2135793-73-4 cas:125220-94-2 |
99 |
h |
2024-12-25 |
70797 |
mPEG-6-OCH2CH2COOH cas:874208-91-0 |
75 |
h |
2024-12-25 |
70798 |
DOTA-tris(acid)-amido-dPEG (R)11-bromoacetamide,大环配体 |
79 |
kx |
2024-12-25 |
70799 |
DOTA-tris(acid)-amido-dPEG (R)3-bromoacetamide,大环化合物 |
72 |
kx |
2024-12-25 |
70800 |
Propargyl-C8-amido-PEG2-NHS ester,1006592-59-1 ,抗体- 药物偶联物 |
66 |
hyy |
2024-12-25 |
70801 |
DOTA-TRIS(ACID)-AMIDO-DPEG 11-BROMOACETAMIDE,大环化合物 |
89 |
kx |
2024-12-25 |
70802 |
92943-93-6,多它灵,gadolinium DOTA meglumine,大环化合物 |
171 |
kx |
2024-12-25 |
70803 |
Propargyl-NH-PEG3-C2-NHS ester,1214319-94-4,ADC试剂 |
65 |
hyy |
2024-12-25 |
70804 |
脂质体包裹四氧化三铁磁性纳米颗粒,Fe₃O₄@liposome |
261 |
axc |
2024-12-25 |
70805 |
T1/T2造影剂脂质体,定制服务 |
78 |
axc |
2024-12-25 |
70806 |
T1/T2造影剂脂质体,定制服务 |
70 |
axc |
2024-12-25 |
70807 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)ethyl]amino]-2-oxoethyl]-, 1,4,7-tris(1,1-dimethylethyl) ester,大环化合物 |
79 |
kx |
2024-12-25 |
70808 |
盐霉素&氯喹共载脂质体,脂质体定制服务 |
66 |
axc |
2024-12-25 |
70809 |
阿霉素&功能核酸共载脂质体,定制服务 |
90 |
axc |
2024-12-25 |
70810 |
CAS:149819-85-2,Iron DOTA Sodium Salt,大环配体 |
113 |
kx |
2024-12-25 |
70811 |
胞苷酸脂质体,脂质体定制服务 |
81 |
axc |
2024-12-25 |
70812 |
Gd-DOTA-NHS,GD-羟基琥珀酰亚胺DOTA活性酯,大环化合物 |
78 |
kx |
2024-12-25 |
70813 |
雷帕霉素纳米粒脂质体,脂质体定制服务 |
139 |
axc |
2024-12-25 |
70814 |
DOTA-tris(TBE)-amido-dPEG (R)4-TFP ester,大环配体 |
65 |
kx |
2024-12-25 |
70815 |
超声介导LHRHa靶向紫杉醇脂质体—微泡耦联体 |
73 |
axc |
2024-12-25 |
70816 |
超声介导LHRHa靶向紫杉醇脂质体—微泡耦联体 |
83 |
axc |
2024-12-25 |
70817 |
Mal-Ph-CONH-PEG4-NHS ester,1263044-88-7,ADC试剂 |
85 |
hyy |
2024-12-25 |
70818 |
HER2为靶点的靶向纳米级脂质微泡,脂质体定制服务 |
78 |
axc |
2024-12-25 |
70819 |
mPEG16-OH cas:133604-58-7 甲氧基十六聚乙二醇-羟基 |
69 |
h |
2024-12-25 |
70820 |
DOTA-tris(TBE)-amido-dPEG (R)24-TFP ester,大环化合物 |
78 |
kx |
2024-12-25 |
70821 |
NGR(Asn-Gly-Arg)多肽修饰的主动靶向脂质体,DSPE-PEG-NGR |
289 |
axc |
2024-12-25 |
70822 |
转铁蛋白transferrin修饰的主动靶向脂质体,DSPE-PEG-transferrin |
119 |
axc |
2024-12-25 |
70823 |
NH2-PEG4-DOTA,氨基-四聚乙二醇-DOTA |
68 |
kx |
2024-12-25 |
70824 |
叶酸folate修饰的主动靶向脂质体,DSPE-PEG-FA |
186 |
axc |
2024-12-25 |
70825 |
Mal-CO-PEG5-NHS ester,1232769-29-7,抗体- 药物偶联物 |
86 |
hyy |
2024-12-25 |
70826 |
508172-24-5,化合物 T33068,Lysine-DOTA,大环化合物 |
73 |
kx |
2024-12-25 |
70827 |
IRGD/RGD/CRGD修饰的主动靶向脂质体,DSPE-PEG-RGD |
123 |
axc |
2024-12-25 |
70828 |
HO-PEG4-CH2CH3 cas:5650-20-4 |
94 |
zyl |
2024-12-25 |
70829 |
mPEG9-NH2 cas:211859-73-3 甲氧基九聚乙二醇-氨基 |
66 |
h |
2024-12-25 |
70830 |
ICG荧光脂质体,吲哚菁绿脂质体 |
123 |
axc |
2024-12-25 |